Author:
Gross Cary P.,Galusha Deron H.,Krumholz Harlan M.
Publisher
Springer Science and Business Media LLC
Reference34 articles.
1. Levitan N, Dowlati A, Remick S, et al. Rates of initial and recurrent thromboemboloic disease among patients with malignancy versus those without malignancy. Medicine. 1999;78:285–91.
2. Lee AY, Levine MN. Venous thromboembolism and cancer: risks and outcomes. Circulation. 2003;107(23 suppl 1):I17–21.
3. Sorensen HT, Mellemkjaer L, Olsen JH, Baron JA. Prognosis of cancers associated with venous thromboembolism. N Engl J Med. 2000;343(25):1846–50.
4. Prandoni P, Lensing AW, Piccioli A, et al. Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis. Blood. 2002;100(10):3484–8.
5. White RH. The epidemiology of venous thromboembolism. Circulation. 2003;107(23 suppl 1):I4–8.